SLRX Stock Analysis: Buy, Sell, or Hold?
SLRX - Salarius Pharmaceuticals, Inc. Common Stock
$0.84
0.19 (29.23%)
▲
5d:
+29.71%
30d:
-0.01%
90d:
-81.42%
HOLD
MODERATE Confidence
Last Updated: January 7, 2026
Get Alerted When SLRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: SLRX is 13.5% above fair value ($0.74). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: SLRX is 13.5% above fair value ($0.74). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: SLRX is currently trading at $0.84, which is considered extended relative to its 30-day fair value range of $0.58 to $0.74.
Technical Outlook: Technically, SLRX is in a strong downtrend. Immediate support is located at $0.51, while resistance sits at $0.90. The stock is showing strong short-term momentum, up 29.2% recently.
Market Sentiment: SLRX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $26.00 (+2995.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SLRX is in a strong downtrend. Immediate support is located at $0.51, while resistance sits at $0.90. The stock is showing strong short-term momentum, up 29.2% recently.
Market Sentiment: SLRX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $26.00 (+2995.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$0.58 -
$0.74
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BEARISH: Price significantly overextended (+13.5% above fair value)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+29.2%)
- BULLISH: Trading 2995.2% below Wall St target ($26.00)
Fair Price Analysis
30-Day Fair Range
$0.58 -
$0.74
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$0.51
Resistance Level
$0.90
Current Trend
Strong Downtrend
Fundamental Context
Wall Street Target
$26.00
(+2995.2%)
Revenue Growth (YoY)
-100.0%
Last updated: February 03, 2026 2:36 AM ET
Data refreshes hourly during market hours. Next update: 3:36 AM
Data refreshes hourly during market hours. Next update: 3:36 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SLRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 58 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$93 | 60 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 55 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$34 | 51 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$71 | 60 HOLD |
